Biomarkers for Colorectal Cancer

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2010 Oct 20

PMID 20957089

Citations 53

Authors

Takuji Tanaka

Mayu Tanaka

Takahiro Tanaka

Rikako Ishigamori

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is the third most common epithelial malignancy in the world. Since CRC develops slowly from removable precancerous lesions, detection of the lesion at an early stage by regular health examinations can reduce the incidence and mortality of this malignancy. Colonoscopy significantly improves the detection rate of CRC, but the examination is expensive and inconvenient. Therefore, we need novel biomarkers that are non-invasive to enable us to detect CRC quite early. A number of validation studies have been conducted to evaluate genetic, epigenetic or protein markers for identification in the stool and/or serum. Currently, the fecal occult blood test is the most widely used method of screening for CRC. However, advances in genomics and proteomics will lead to the discovery of novel non-invasive biomarkers.

Citing Articles

Utility of Stool-Based Tests for Colorectal Cancer Detection: A Comprehensive Review.

Gomez-Molina R, Suarez M, Martinez R, Chilet M, Bauca J, Mateo J Healthcare (Basel). 2024; 12(16).

PMID: 39201203 PMC: 11353969. DOI: 10.3390/healthcare12161645.

Serum IGFBP-1 as a promising diagnostic and prognostic biomarker for colorectal cancer.

Huang B, Wei L, Lin Y, Huang L, Qu Q, Li X Sci Rep. 2024; 14(1):1839.

PMID: 38246959 PMC: 10800337. DOI: 10.1038/s41598-024-52220-2.

Extracellular Vesicle Membrane Protein Profiling and Targeted Mass Spectrometry Unveil CD59 and Tetraspanin 9 as Novel Plasma Biomarkers for Detection of Colorectal Cancer.

Dash S, Wu C, Wu C, Chiang S, Lu Y, Yeh C Cancers (Basel). 2023; 15(1).

PMID: 36612172 PMC: 9818822. DOI: 10.3390/cancers15010177.

Recent Advances in Inflammatory Diagnosis with Graphene Quantum Dots Enhanced SERS Detection.

Mousavi S, Hashemi S, Kalashgrani M, Kurniawan D, Gholami A, Rahmanian V Biosensors (Basel). 2022; 12(7).

PMID: 35884264 PMC: 9313165. DOI: 10.3390/bios12070461.

Identification of key candidate genes and pathways associated with colorectal aberrant crypt foci-to-adenoma-to-carcinoma progression.

Fayazfar S, Arefi Oskouie A, Safaei A, Zali H, Nazemalhosseini Mojarad E Gastroenterol Hepatol Bed Bench. 2022; 14(Suppl1):S41-S50.

PMID: 35154601 PMC: 8817750.

References

Booth R . Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Lett. 2007; 249(1):87-96. DOI: 10.1016/j.canlet.2006.12.021. View

Tost J . DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Methods Mol Biol. 2008; 507:3-20. DOI: 10.1007/978-1-59745-522-0_1. View

Schneider J, Bitterlich N, Schulze G . Improved sensitivity in the diagnosis of gastro-intestinal tumors by fuzzy logic-based tumor marker profiles including the tumor M2-PK. Anticancer Res. 2005; 25(3A):1507-15. View

Sorensen K, Orntoft T . Discovery of prostate cancer biomarkers by microarray gene expression profiling. Expert Rev Mol Diagn. 2009; 10(1):49-64. DOI: 10.1586/erm.09.74. View

Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L . Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest. 2008; 118(7):2600-8. PMC: 2402113. DOI: 10.1172/JCI34934. View

Wu C, Chen H, Chen S, Liu H, Hsieh Y, Yu C . Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics. 2008; 8(2):316-32. DOI: 10.1002/pmic.200700819. View

Zhang B, Chen J, Chen D, Wang G, Shen P . Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls. World J Gastroenterol. 2004; 10(11):1643-6. PMC: 4572770. DOI: 10.3748/wjg.v10.i11.1643. View

Holten-Andersen M, Stephens R, Nielsen H, Murphy G, Christensen I, Brunner N . High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res. 2000; 6(11):4292-9. View

Yu S, Chen H, Chang G, Chen C, Chen H, Singh S . MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008; 13(1):48-57. DOI: 10.1016/j.ccr.2007.12.008. View

10.

Ho L, Fivecoat H, Wang J, Pasinetti G . Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications. Exp Gerontol. 2009; 45(1):15-22. PMC: 2840994. DOI: 10.1016/j.exger.2009.09.007. View

11.

Hundt S, Haug U, Brenner H . Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev. 2007; 16(10):1935-53. DOI: 10.1158/1055-9965.EPI-06-0994. View

12.

Kronborg O, Fenger C, Olsen J, Jorgensen O, Sondergaard O . Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348(9040):1467-71. DOI: 10.1016/S0140-6736(96)03430-7. View

13.

Loktionov A, ONeill I, Silvester K, Cummings J, Middleton S, Miller R . Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin Cancer Res. 1998; 4(2):337-42. View

14.

Zhu J, Yao X . Use of DNA methylation for cancer detection and molecular classification. J Biochem Mol Biol. 2007; 40(2):135-41. DOI: 10.5483/bmbrep.2007.40.2.135. View

15.

Losi L, Roncucci L, Di Gregorio C, de Leon M, Benhattar J . K-ras and p53 mutations in human colorectal aberrant crypt foci. J Pathol. 1996; 178(3):259-63. DOI: 10.1002/(SICI)1096-9896(199603)178:3<259::AID-PATH473>3.0.CO;2-4. View

16.

Takahashi M, Wakabayashi K . Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci. 2004; 95(6):475-80. PMC: 11158569. DOI: 10.1111/j.1349-7006.2004.tb03235.x. View

17.

Magnani J, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, KOPROWSKI H . A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem. 1982; 257(23):14365-9. View

18.

Shaw R, Cantley L . Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. 2006; 441(7092):424-30. DOI: 10.1038/nature04869. View

19.

Akao Y, Nakagawa Y, Naoe T . MicroRNA-143 and -145 in colon cancer. DNA Cell Biol. 2007; 26(5):311-20. DOI: 10.1089/dna.2006.0550. View

20.

Kan T, Meltzer S . MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol. 2009; 9(6):727-32. PMC: 2794797. DOI: 10.1016/j.coph.2009.08.009. View